GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma

GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma

Immunotherapy based on immune checkpoint inhibitors (ICIs) is considered to be a promising treatment for stomach adenocarcinoma (STAD), but only a minority of patients benefit from it. It is believed that the poor therapeutic efficacy is attributed to the complex tumor immune microenvironment (TIM)...

Full description

Bibliographic Details
Main Authors:	Lin Ni, Shuming Chen, Jianyong Liu, He Li, Hu Zhao, Chunhua Zheng, Yawei Zhang, Hancong Huang, Junjie Huang, Bing Wang, Chengzhi Lin
Format:	Article
Language:	English
Published:	Hindawi Limited 2023-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2023/7123568

Similar Items

Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma
by: Dun Pan, et al.
Published: (2023-11-01)

Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma
by: Lili Guo, et al.
Published: (2022-08-01)

IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma
by: Guo L, et al.
Published: (2021-12-01)

A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma
by: Muhammad Khan, et al.
Published: (2022-10-01)

Exploring the Correlation Between GPR176, a Potential Target Gene of Gastric Cancer, and Immune Cell Infiltration
by: Gu X, et al.
Published: (2023-06-01)

High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells
by: Yu Zhang, et al.
Published: (2023-06-01)

Increased <i>SEC23A</i> Expression Correlates with Poor Prognosis and Immune Infiltration in Stomach Adenocarcinoma
by: Su Zhaoran, et al.
Published: (2023-03-01)

DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis
by: Lu Y, et al.
Published: (2022-07-01)

Identification of miRNA biomarkers for stomach adenocarcinoma
by: Hao Qian, et al.
Published: (2022-05-01)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
by: Hui Li, et al.
Published: (2023-06-01)

The Interactions Between GPR30 and the Major Biomarkers in Infiltrating Ductal Carcinoma of the Breast in an Asian Population
by: Wen-Hung Kuo, et al.
Published: (2007-06-01)

Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma
by: Yiyan Zhai, et al.
Published: (2023-01-01)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
by: Taohua Yue, et al.
Published: (2021-08-01)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
by: Chen Han, et al.
Published: (2021-12-01)

Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma
by: Dandan Zhu, et al.
Published: (2022-03-01)

Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach
by: Muxing Kang, et al.
Published: (2022-05-01)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
by: Lin Li, et al.
Published: (2023-03-01)

Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling
by: Chunhua Liu, et al.
Published: (2022-08-01)

Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
by: Xiaohui Wang, et al.
Published: (2023-02-01)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
by: Yu Zhang, et al.
Published: (2023-08-01)

Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
by: Wei Yu, et al.
Published: (2022-09-01)

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration
by: Jinjie Wang, et al.
Published: (2022-06-01)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
by: Jing Yang, et al.
Published: (2022-12-01)

Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma
by: Jing Yang, et al.
Published: (2023-04-01)

Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma
by: Qingjun Wang, et al.
Published: (2022-06-01)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
by: Zhengyang Fan, et al.
Published: (2023-01-01)

A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma
by: Linlan Jiang, et al.
Published: (2022-03-01)

Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas
by: Guo-Liang Zheng, et al.
Published: (2022-04-01)

An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
by: Yichen Tang, et al.
Published: (2014-01-01)

PLXNC1: A Novel Potential Immune-Related Target for Stomach Adenocarcinoma
by: Zhizhan Ni, et al.
Published: (2021-07-01)

GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer
by: Junwei Tang, et al.
Published: (2023-04-01)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
by: Tianyou Liao, et al.
Published: (2022-10-01)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
by: Bangjie Chen, et al.
Published: (2022-07-01)

Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis
by: Chunhong Hong, et al.
Published: (2021-03-01)

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer
by: Junpeng Liu, et al.
Published: (2023-01-01)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
by: Wenting Liu, et al.
Published: (2021-03-01)

Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma
by: Zejian Lyu, et al.
Published: (2022-03-01)

Hepatoid adenocarcinoma of the stomach: CT findings
by: Qian Yang, et al.
Published: (2023-02-01)

Gastropericardial fistula complicating an adenocarcinoma of the stomach
by: A. S. Shaik, et al.
Published: (1998-05-01)

LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
by: Lin Z, et al.
Published: (2021-11-01)